5 ms·
Isn't this a deliberate model, and not only for pharma? Govt funds the risky research, and then hands the baton to competitive industry, which is good at 'find
by jacknews 4y ago
Isn't this a deliberate model, and not only for pharma?
Govt funds the risky research, and then hands the baton to competitive industry, which is good at 'finding markets', making it a product, and optimizing costs.
Eg, google, amazon, etc, would not exist without the govt early (and continuing) funding of the tech their business is based on.
What is then supposed to happen is that profits are taxed sufficiently, feeding back in to the system, but that part appears to have broken down lately.
- efficax 4y agoyes, it’s deliberate. it’s a deliberate way of using taxpayer dollars to enrich private citizens without providing taxpayer benefits.
- Arnt 4y agoIf that's right, shouldn't there be a flood of new companies looking to get the dollars? Is there such a flood, or at least a stream? I haven't noticed one, but I don't really try…
- pessimizer 4y agoIt's not a program to support small businesses, it's a structure to support massive companies who lobby and hire politicians and their friends and family.
- Arnt 4y agoIn that case, shouldn't there be a flood, or at least a stream, of existing big companies setting up new subsidiaries to take advantage of this? There are many big companies with existing lobbyist divisions, deep pockets and experience in broadly similar areas. Food, cosmetics, chemicals spring to mind.
- colinsane 4y ago> What is then supposed to happen is that profits are taxed sufficiently, feeding back in to the system, but that part appears to have broken down lately. right. with the right accounting processes, i could buy the rest. but when spending and tax collection are as decoupled or loosely balanced as they appear to be today, public investment into private industry is super risky.
- Throwawayaerlei 4y agoOnly read the beginning of this screed, but its a unique and unlikely to be repeated situation until the next pandemic model. "Competitive industry" normally spends the big bucks to do Phase II and especially expensive Phase III trials. And as you note, manufacturing it. Which Pfizer did without Operation Warp Speed money until it started failing to deliver on its promises in December 2020. May have gotten some money from Germany through BioNTech which was the company that actually developed it. The claim "By one estimate, the National Institutes of Health spent $17 billion on vaccine technologies fundamental to the Covid-19 vaccine." goes back to the mid-20th Century, is so broad as to be useless and is obviously disqualifying propaganda: https://medicalxpress.com/news/2021-04-covid-vaccine-built-billion-nih.html https://medicalxpress.com/news/2021-04-covid-vaccine-built-b...
- cdtwigg 4y agoYeah it’s the trials that are really expensive, not the basic research. The government gets to spread its dollars around to lots of individual researchers but if they were instead using that money to fund phase III trials (1) we’d have a lot a lot less money for basic research (2) we’d fund a lot fewer phase III trials so (3) we’d see much less drug development overall. Also I’d worry about a potential conflict of interest if the same government is conducting and evaluating the results of drug trials.
- s1artibartfast 4y agoNever mind the fact that 17 billion is on par with the annual R&D spend at one Pharma company. I think a more interesting comparison would be all national funding for drug R&D versus all corporate R&D funding. This could be done on an annual basis or historic. NIH budget was 43 billion in 2021 for all healthcare sectors Top 10 US Drug company[1] R&D budgets [2] were: 1: Johnson & Johnson $15 Billion 2: Pfizer $14 Billion 3: Merck $13 Billion 4: AbbVie $7 Billion 5: Bristol $11 Billion 6: Abbott $3 Billion 7: Amgen $5 Billion 8: Gilead $5 Billion 9: Eli Lilly $7 Billion 10: Biogen 2.5 Billion Total 91+ Billion Keep in mind that those are only US headquartered drug companies, and some of the biggest players like Roche and Novartis are in Europe[3] https://www.pharmapproach.com/top-10-pharmaceutical-companies-in-the-united-states/ https://www.pharmapproach.com/top-10-pharmaceutical-companie... https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/research-development-expensese https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnso... https://www.fiercebiotech.com/special-reports/top-10-pharma-rd-budgets-2021 https://www.fiercebiotech.com/special-reports/top-10-pharma-...
- rayiner 4y agoEconomists broadly agree that taxing corporate profits is inefficient. From an NPR show surveying five economists across the political spectrum about what are consensus ideas in the field: https://www.npr.org/sections/money/2012/07/19/157047211/six-policies-economists-love-and-politicians-hate https://www.npr.org/sections/money/2012/07/19/157047211/six-... (“Eliminate the corporate income tax. Completely. If companies reinvest the money into their businesses, that's good. Don't tax companies in an effort to tax rich people.”). The problem in the US isn’t that we don’t tax Google, Amazon, etc. Look at the corporate taxes in France or Sweden. They’re about the same. The problem is that we don’t sufficiently tax the billions in payroll at those companies.
- sneak 4y ago> The problem is that we don’t sufficiently tax the billions in payroll at those companies. The government isn’t short on money. Are we sure that the problem isn’t that we are spending Elon Musk’s entire lifetime net worth on the military each and every 90 days while not even at war? We shovel twenty tons of hundred dollar bills (about $2bn) into the neverending pit of the war machine every day. I’m not convinced more government revenue is the solution to any problems, given what they are doing with their current insanely large levels of revenue at present.
- rayiner 4y ago> The government isn’t short on money. It surely is. The federal government ran a $880 billion deficit in 2018. > Are we sure that the problem isn’t that we are spending Elon Musk’s entire lifetime net worth on the military each and every 90 days while not even at war? Yes, definitely. Total government spending at all levels (federal + state + local) is about $7 trillion. The military budget is only 1/10 of that. If we cut our defense spending to the NATO 2% of GDP target, we would save only about $300 billion. We need to cut twice that just to close the structural deficit, and raise taxes by about another trillion to pay for universal healthcare.
- candiodari 4y ago> It surely is. The federal government ran a $880 billion deficit in 2018. You do realise the government is supposed to run a deficit, right? That's quite literally where money comes from. You can make the case that it's too big ... and it is, but it should run a deficit.
- s1artibartfast 4y ago>What is then supposed to happen is that profits are taxed sufficiently, feeding back in to the system, but that part appears to have broken down lately. How do you figure? Tax revenues are basically at all time high, and going up further. Consider that 40% of US GDP now is collected in some form of taxation.[1] 40 cents of every dollar earned is taxed and spent as the government chooses. This is more than between FDR and Regan, and much more than the 20s (~15% of GDP) Also consider that size of the pie has also increased! US real GDP per capita (accounting for inflation) has grown ~4x since the 1940s, and total GDP has grown ~20x! [2] https://upload.wikimedia.org/wikipedia/commons/3/37/Federal%2C_state%2C_and_local_tax_revenue_as_a_percent_of_GDP.pdf https://upload.wikimedia.org/wikipedia/commons/3/37/Federal%... https://fred.stlouisfed.org/series/A939RX0Q048SBEA https://fred.stlouisfed.org/series/A939RX0Q048SBEA